E

Edgewise Therapeutics

65 employees

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biopharma

Date founded

2017

Funding rounds raised

Total raised

$95M

from 9 investors over 9 rounds

E

Edgewise Therapeutics raised $95M on December 8, 2020

Investors: Logos Global Management, LP, Wellington Management, RA Capital Management, L.P., Viking Global Investors, Surveyor Capital and OrbiMed Advisors

E

Edgewise Therapeutics raised $50M on September 17, 2019

Investors: New Leaf Venture Partners, OrbiMed Advisors and Novo Holdings

FAQ